[Assessment of myocardial contraction and relaxation with 99mTc-tetrofosmin multi-gated myocardial SPECT]. 1994

I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
Department of Radiology, Osaka Medical College.

Myocardial relaxation at the diastolic phase was not evaluated by multi-gated myocardial SPECT, although myocardial contraction at the systolic phase was studied by percent wall thickening and Bull's eye methods. We make out a myocardial volume curve and report to evaluate the myocardial relaxation using multi-gated myocardial SPECT. The study population consisted of 3 normal human subjects (3 male, 32-37 years old), 10 idiopathic cardiomyopathy, 10 coronary artery disease and 1 hypertensive heart disease combined with aortic regurgitation. All cases were injected 555 MBq of 99mTc-tetrofosmin (Amersham Healthcare Corporation) intravenously at rest. A triple detector gamma-camera (GCA-9300A, Toshiba Medical, Japan) and a data processing computer (GMS-5500A, Toshiba Medical, Japan) were used in this study. A cardiac cycle (R-R interval) was divided by 16 frames (50-80 msec per 1 frame). Eight myocardial volume curves were calculated at the anterior wall, apex and inferior wall of the vertical long axis view and were calculated at the septal wall, apex and lateral wall of the horizontal long axis view, respectively. The patterns of the myocardial volume curves were classified into 5 patterns (Normal pattern (N), Delayed Contraction pattern (DC), Delayed Relaxation pattern (DR), Mixed pattern (M) and Normal pattern with Decreased amplitude (ND)). Myocardial uptake was evaluated visually of grading into severe hypertrophy (5), hypertrophy (4), normal (3), mild hypoperfusion (2), hypoperfusion (1) and perfusion defect (0). We compared patterns of the myocardial volume curves to myocardial uptake in the same segments. It was possible to detect myocardial edge of the total 16 frames with 50-60% threshold in the normal volunteer and in patients with hypertrophic cardiomyopathy and to make a myocardial volume curve. The region of the severe myocardial perfusion defect could be detected with 20% threshold in patients with old myocardial infarction. In comparison with myocardial volume curves and myocardial uptake, 74.6% in the N pattern had a normal uptake (3), 66.7% in the ND pattern had a normal uptake (3), 61.5% in the DC pattern had a hypoperfusion segment (0, 1 or fill-in to normal uptake), 44.4% in the DR pattern had a hypertrophic segment (4, 5 or fill-in to increased uptake). The pattern of myocardial volume curve indicates myocardial contractility and relaxation in each myocardial segment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D003971 Diastole Post-systolic relaxation of the HEART, especially the HEART VENTRICLES. Diastoles
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
November 1996, Kaku igaku. The Japanese journal of nuclear medicine,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
February 2005, Nuclear medicine communications,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
October 1999, Revista espanola de medicina nuclear,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
October 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
November 1995, Kaku igaku. The Japanese journal of nuclear medicine,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
February 2003, Annals of nuclear medicine,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
July 1998, Kaku igaku. The Japanese journal of nuclear medicine,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
April 2003, Annals of nuclear medicine,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
June 2007, European journal of clinical investigation,
I Adachi, and Y Sugioka, and K Tabuchi, and K Yamamoto, and Y Tatsu, and Y Saika, and H Nishigaki, and R Matsui, and K Sueyoshi, and I Narabayashi
April 1997, Kaku igaku. The Japanese journal of nuclear medicine,
Copied contents to your clipboard!